GBI Research’s report: “Facial
Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as
Increasing Awareness Fuels Demand in Developing Markets” discusses the market,
competitive landscape, and trends for two facial aesthetics market segments:
Botox and dermal fillers. It provides comprehensive information on the key
trends affecting these segments, and key analytical content on the dynamics of
the market. The report also reviews the competitive landscape, analyzes each
segment’s pipeline products and gives details of important merger and
acquisition deals. It is built using data and information sourced from
proprietary databases, primary and secondary research and in-house analysis by
GBI Research’s team of industry experts.
Visit Complete Report Here: http://www.marketresearchreports.biz/analysis-details/facial-aesthetics-market-to-2020-economic-recovery-drives-growth-in-the-us-as-increasing-awareness-fuels-demand-in-developing-markets
Scope
- Key geographies: US, Brazil,
Germany, Turkey, France, Italy, Spain, Japan, China, India, Columbia and
South Korea.
- Information on market size for
two facial aesthetics market segments: botox and dermal fillers.
- Annualized market revenue data
forecast to 2020 and company share data for 2013.
- Qualitative analysis of key
trends in the facial aesthetics market.
- Information on the competitive
landscape and the leading technologies of key players
Reasons to Buy
- Develop business strategies by
understanding the trends and developments driving the global facial
aesthetics market.
- Design and enhance your
product development, marketing, and sales strategies.
- Exploit merger and acquisition
opportunities by identifying the market players with the most innovative
pipelines.
- Develop market-entry and
market-expansion strategies.
- Identify the key players best
positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and
out-licensing opportunities by identifying the products most likely to
ensure a robust return.
- Identify, understand and
capitalize emerging blockbusters of the facial aesthetics market
landscape.
- Make more informed business
decisions from insightful and in-depth analysis of the global facial
aesthetics market and the factors shaping it.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Executive Summary 11
2.1 Facial Aesthetics Market
Expected to Grow Rapidly during the Forecast Period 11
2.2 Allergan Dominates the Global
Facial Aesthetics Market 12
2.3 US will Continue to be the
Largest Market for Facial Aesthetics 13
2.4 Hyaluronic Acid Fillers the
Fastest Growing Segment due to Greater Affordability and Good Safety Profiles
15
2.5 Global Facial Aesthetics Market
has High Exposure to Economic Volatility 16
3 Introduction 18
3.1 GBI Research Report Guidance 18
4 Analyst Commentary 19
5 Global Facial Aesthetics Market:
Device Overview 21
5.1 Facial Aesthetics 21
5.1.1 Dermal Fillers 21
5.1.2 Particle and Polymer Fillers
21
5.1.3 Botox 21
6 Global Facial Aesthetics Market:
Market Characterization 22
6.1 Global Facial Aesthetics
Market, Revenue, 2006–2020 22
6.2 Botox Market, Global, Key
Company Shares, 2013 23
6.3 Dermal Fillers Market, Global,
Key Company Shares, 2013 26
6.4 Facial Aesthetics Market, Key
Trends 28
6.4.1 Topical Neurotoxins to Drive
Future Growth of Botox Market 29
6.4.2 Companies Focus on Autologous
Injectables for Sustained Future Growth 30
6.4.3 Survey Results Indicate
Expanding Patient Demographics for Facial Injectables 31
6.5 Market Dynamics 32
6.5.1 Market Drivers 32
6.5.2 Market Restraints 37
7 Global Facial Aesthetics Market:
Segment Analysis and Forecasts 39
7.1 Botox Market, Global, Revenue,
2006–2020 39
7.2 Dermal Fillers Market, Global,
Revenue, 2006–2020 40
8 Global Facial Aesthetics Market:
Country Analysis and Forecasts 43
8.1 Facial Aesthetics Market:
Cross-country Analysis 43
8.2 Historic and Forecast Revenue
and Volume, by Country 45
8.2.1 Facial Aesthetics Market, US,
Revenue and Volume, 2006–2020 45
8.2.2 Facial Aesthetics Market,
Japan, Revenue and Volume, 2006–2020 47
8.2.3 Facial Aesthetics Market,
Germany, Revenue and Volume, 2006–2020 50
8.2.4 Facial Aesthetics Market,
France, Revenue, 2006–2013 53
8.2.5 Facial Aesthetics Market,
Korea, Revenue and Volume, 2006–2020 56
8.2.6 Facial Aesthetics Market,
Spain, Revenue, Volume, 2006–2020 58
8.2.7 Facial Aesthetics Market,
Italy, Revenue, Volume, 2006–2020 60
8.2.8 Facial Aesthetics Market,
Colombia, Revenue, Volume, 2006–2020 62
8.2.9 Facial Aesthetics Market,
China, Revenue, Volume, 2006–2020 64
8.2.10 Facial Aesthetics Market,
Turkey, Revenue, Volume, 2006–2020 66
8.2.11 Facial Aesthetics Market,
India, Revenue, 2006–2013 68
8.2.12 Facial Aesthetics Market,
Brazil, Revenue, 2006–2020 70
9 Global Facial Aesthetics Market:
Competitive Landscape 72
9.1 Comparison of Leading Botox
Brands, 2014 72
9.2 Comparison of Leading
Hyaluronic Acid-Based Fillers, 2014 74
9.3 Global Facial Aesthetics Market,
Competitive Assessment 77
9.4 Company Profiles 78
9.4.1 Allergan 78
9.4.2 Merz Aesthetics 79
9.4.3 Galderma 79
9.4.4 Valeant Pharmaceuticals
International 80
9.4.5 Mentor Worldwide 81
9.4.6 Anika Therapeutics 81
9.4.7 Anteis 82
9.4.8 Adoderm 83
9.4.9 Alcon Laboratories 83
9.4.10 BioPolymer 84
9.4.11 Contura International 84
9.4.12 LCA Pharmaceutical 85
9.4.13 Laboratories Orgév 85
9.4.14 Polymekon 86
9.4.15 Prollenium Medical
Technologies 86
9.4.16 Teoxane 87
9.4.17 Zimmer 87
9.4.18 Suneva Medical 88
9.4.19 Revitacare 89
9.4.20 Medytox 89
9.4.21 HuGel 90
10 Global Facial Aesthetics Market:
Product Pipeline Analysis 91
10.1 Facial Aesthetics Market: List
of Pipeline Products 92
10.1.1 Dermal Fillers, List of
Pipeline Products 92
10.1.2 Botox, List of Pipeline
Products 93
10.2 Facial Aesthetics Market:
Profiles of Key Pipeline Products 94
10.2.1 Aquamid 94
10.2.2 Autologous Globin Dermal
Filler 94
10.2.3 BioDermal Filler 94
10.2.4 Collagen Scaffold –
Aesthetic Procedures 95
10.2.5 Dermal Filler 95
10.2.6 Dermal Filler 96
10.2.7 Gold Nanoparticle Dermal
Filler 96
10.2.8 Hyaluderm 97
10.2.9 Injectable Dermal Filler 97
10.2.10 Juvéderm Volbella 98
10.2.11 Juvéderm Volift 98
10.2.12 Juvéderm Voluma XC 99
10.2.13 Macdermol 18 99
10.2.14 Macdermol 21 100
10.2.15 Macdermol 24 100
10.2.16 Macdermol 30 101
10.2.17 Macdermol Bio Lift 101
10.2.18 Macdermol Bio Revitalization
102
10.2.19 Macdermol Body Contour 103
10.2.20 Macdermol Hydro 103
10.2.21 Macdermol Lips 104
10.2.22 MacDermol R 104
10.2.23 MacDermol S 105
10.2.24 Macdermol Scalp Stimulation
105
10.2.25 Macdermol Volume 106
10.2.26 Matridex 106
10.2.27 Matridur 107
10.2.28 Matrigel 107
10.2.29 Next Generation Elevess
Dermal Filler 108
10.2.30 Puragen 108
10.2.31 Puragen Plus 109
10.2.32 Restylane Touch 109
10.2.33 Tenergel 110
10.2.34 Wrinkle Filler 110
10.2.35 RT-001 111
10.2.36 RT-002 111
10.2.37 ANT-1207 112
10.2.38 NT-201 112
11 Facial Aesthetics Market: Consolidation Landscape 113
11.1 Key Deals, 2014 113
11.1.1 Valeant’s Offer to Buy
Allergan, 2014 113
11.1.2 Deal Rationale 113
11.2 Key Deals (2009–2013) 114
11.2.1 Merz’s Acquisition of Anteis,
2013 114
11.2.2 Valeant’s Acquisition of
Medicis, 2012 114
11.2.3 Merz Completes Acquisition
of BioForm Medical, 2010 114
11.2.4 Galderma’s Acquisition of
Q-Med, 2010 114
11.2.5 Johnson & Johnson’s
Acquisition of Mentor, 2009 115
12 Appendix 116
Office: United States
|
State Tower
90 State Street, Suite 700 Albany, NY 12207 United States |
No comments:
Post a Comment